Offstream
news

A World Health Organization (WHO) panel of International experts recommends the use of Merck & Co.'s COVID-19 antiviral pill Molnupiravir for high-risk patients.
2022-03-2

The Belgian government finalizes an agreement to buy 20,000 courses of Pfizer's Paxlovid COVID-19 drug and Merck & Co.'s Molnupiravir COVID-19 drug.
2022-01-3

The Danish Health Authority approves the usage of the Molnupiravir antiviral pill developed by Merck & Co. for at-risk patients with symptoms, becoming the first EU country to authorize the usage of this drug.
2021-12-16

The Swiss government signs a deal to reserve 8,640 doses of Merck & Co.'s antiviral drug molnupiravir beginning in January.
2021-11-23

The government announces that they will obtain 1.6 million doses of Merck & Co.'s molnupiravir and have also increased hospital capacities for COVID-19 patients to 30% in order to prepare for a sixth wave of the pandemic.
2021-11-12

Merck & Co. signs a licensing agreement with the UN-backed Medicines Patent Pool that will allow more companies to manufacture generic versions of its experimental oral antiviral COVID-19 treatment molnupiravir with a royalty-free license that will apply to 105 low- and middle-income countries.
2021-10-27

U.S. President Joe Biden announces that Merck & Co. will produce single-shot Johnson & Johnson vaccine to help his administration goal for vaccinating every adult by the end of May.
2021-03-2

Pharmaceutical giant Merck & Co. announces that it will purchase Peloton Therapeutics Inc. for $1.05 billion in cash. The catalyst for the deal is Peloton's recent progress in the development of a kidney cancer treatment.
2019-05-21

The United States Food and Drug Administration approves the Merck & Co. drug, Bridion, that reverses the effects of muscle relaxants used during surgery.
2015-12-15

Merck & Co. agrees to buy Idenix Pharmaceuticals for US$3.85 billion.
2014-06-9